Cargando…

The alternative complement pathway revisited

Alternative pathway amplification plays a major role for the final effect of initial specific activation of the classical and lectin complement pathways, but the quantitative role of the amplification is insufficiently investigated. In experimental models of human diseases in which a direct activati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harboe, Morten, Mollnes, Tom Eirik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2008
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3865650/ https://www.ncbi.nlm.nih.gov/pubmed/18419792 http://dx.doi.org/10.1111/j.1582-4934.2008.00350.x

Ejemplares similares

The Role of Complement in Liver Injury, Regeneration, and Transplantation
por: Thorgersen, Ebbe Billmann, et al.
Publicado: (2019)

The alternative complement pathway is dysregulated in patients with chronic heart failure
por: Shahini, Negar, et al.
Publicado: (2017)

Soluble collectin-12 mediates C3-independent docking of properdin that activates the alternative pathway of complement
por: Zhang, Jie, et al.
Publicado: (2020)

Editorial: The Role of Complement in Health and Disease
por: Cedzyński, Maciej, et al.
Publicado: (2019)

The Alternative Complement Pathway Is Activated Without a Corresponding Terminal Pathway Activation in Patients With Heart Failure
por: Holt, Margrethe Flesvig, et al.
Publicado: (2021)

A role for the terminal C5-C9 complement pathway in idiopathic pulmonary fibrosis
por: Sikkeland, Liv I. B., et al.
Publicado: (2023)

Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients
por: Smedbråten, Julia, et al.
Publicado: (2016)

Heme Interferes With Complement Factor I-Dependent Regulation by Enhancing Alternative Pathway Activation
por: Gerogianni, Alexandra, et al.
Publicado: (2022)

Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study
por: Hokstad, Ingrid, et al.
Publicado: (2019)

Complement Activation in 22q11.2 Deletion Syndrome
por: Grinde, Dina, et al.
Publicado: (2020)

Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases—C3 or C5 emerge together with CD14 as promising targets
por: Barratt-Due, Andreas, et al.
Publicado: (2017)

Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
por: Garred, Peter, et al.
Publicado: (2021)

Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis
por: Nguyen, Thao H. P., et al.
Publicado: (2022)

AMD and the alternative complement pathway: genetics and functional implications
por: Tan, Perciliz L., et al.
Publicado: (2016)

Plasma complement and vascular complement deposition in patients with coronary artery disease with and without inflammatory rheumatic diseases
por: Shields, Kelly J., et al.
Publicado: (2017)

Genetic variability shapes the alternative pathway complement activity and predisposition to complement‐related diseases
por: Rodríguez de Córdoba, Santiago
Publicado: (2022)

Low‐molecular weight inhibitors of the alternative complement pathway
por: Schubart, Anna, et al.
Publicado: (2022)

Complement 1 Inhibitor Is a Regulator of the Alternative Complement Pathway
por: Jiang, Haixiang, et al.
Publicado: (2001)

Functional Analysis of a Novel Complement C5a Receptor 1-Blocking Monoclonal Antibody
por: Cyranka, Leon, et al.
Publicado: (2023)

High mobility group box-1 protein – one step closer to the clinic?
por: Mollnes, Tom Eirik
Publicado: (2008)

The Factor H protein family: The switchers of the complement alternative pathway
por: Lucientes‐Continente, Laura, et al.
Publicado: (2022)

Clinical and Complement Long-Term Follow-Up of a Pediatric Patient with C3 Mutation-Related Atypical Hemolytic Uremic Syndrome
por: Bjerre, Anna, et al.
Publicado: (2018)

Subject Gaps Revisited: Complement Clauses and Complementizer-Trace Effects
por: Tollan, Rebecca, et al.
Publicado: (2021)

THE ROLE OF PROPERDIN IN THE ALTERNATE PATHWAY OF COMPLEMENT ACTIVATION
por: Götze, Otto, et al.
Publicado: (1974)

Quantitative Modeling of the Alternative Pathway of the Complement System
por: Zewde, Nehemiah, et al.
Publicado: (2016)

Mathematical Modelling of Alternative Pathway of Complement System
por: Bakshi, Suruchi, et al.
Publicado: (2020)

Complement Factor D as a Strategic Target for Regulating the Alternative Complement Pathway
por: Barratt, Jonathan, et al.
Publicado: (2021)

Complement C3b contributes to Escherichia coli-induced platelet aggregation in human whole blood
por: Landsem, Anne, et al.
Publicado: (2022)

Glomerular abundance of complement proteins characterized by proteomic analysis of laser-captured microdissected glomeruli associates with progressive disease in IgA nephropathy
por: Paunas, Teodora Ioana Flavia, et al.
Publicado: (2017)

Gene targeting as a therapeutic avenue in diseases mediated by the complement alternative pathway
por: Dreismann, Anna K, et al.
Publicado: (2022)

Heme Interactions as Regulators of the Alternative Pathway Complement Responses and Implications for Heme-Associated Pathologies
por: Tsiftsoglou, Stefanos A.
Publicado: (2023)

Mechanism of action of factor D of the alternative complement pathway
Publicado: (1978)

Alternative Complement Pathway Deregulation Is Correlated with Dengue Severity
por: Nascimento, Eduardo J. M., et al.
Publicado: (2009)

Blockade of Alternative Complement Pathway in Dense Deposit Disease
por: Berthe-Aucejo, Aurore, et al.
Publicado: (2014)

Complement Alternative Pathway Activation in Human Nonalcoholic Steatohepatitis
por: Segers, Filip M., et al.
Publicado: (2014)

Preanalytical classical and alternative complement pathway activity loss
por: Vercauteren, Koen O.A., et al.
Publicado: (2019)

A porcine model of hemodialyzer reactions: roles of complement activation and rinsing back of extracorporeal blood
por: Pethő, Ákos, et al.
Publicado: (2021)

Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes
Publicado: (1980)

SAR443809: a selective inhibitor of the complement alternative pathway, targeting complement factor Bb
por: Rajagopal, Vaishnavi, et al.
Publicado: (2023)

Blood Transcriptome Analysis of Septic Patients Reveals a Long Non-Coding Alu-RNA in the Complement C5a Receptor 1 Gene
por: Emblem, Åse, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ulqe2a0fkke7dj4v9jo88vg5oq